Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
NCT ID | NCT02903160 |
Title | Prostate Cancer Intensive, Non-Cross Reactive Therapy (PRINT) for Castration Resistant Prostate Cancer (CRPC) |
Recruitment | Recruiting |
Gender | male |
Phase | Phase II |
Variant Requirements | No |
Sponsors | Icahn School of Medicine at Mount Sinai |
Indications | |
Therapies |
Abiraterone + Cabazitaxel + Carboplatin + Enzalutamide + Prednisone |
Age Groups: | adult | senior |
Covered Countries | USA |